Umeå University's logo

umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Comparison of creatinine-based methods for estimating glomerular filtration rate in patients with heart failure
Umeå University, Faculty of Medicine, Department of Public Health and Clinical Medicine, Cardiology.ORCID iD: 0000-0001-9319-0242
Umeå University, Faculty of Medicine, Department of Pharmacology and Clinical Neuroscience.
Umeå University, Faculty of Medicine, Department of Public Health and Clinical Medicine, Cardiology.
Umeå University, Faculty of Medicine, Department of Public Health and Clinical Medicine, Cardiology.
Show others and affiliations
2020 (English)In: ESC Heart Failure, E-ISSN 2055-5822, Vol. 7, no 3, p. 1150-1160Article in journal (Refereed) Published
Abstract [en]

Aims: Glomerular filtration rate is an important factor in management of heart failure (HF). Our objective was to validate eight creatinine-based equations for estimating glomerular filtration rate (eGFR) in an HF population against measured glomerular filtration rate.

Methods and results: One hundred forty-six HF patients (mean age 68 +/- 13 years, mean left ventricular ejection fraction 45% +/- 15) within a single-centre hospital that underwent Cr-51-EDTA clearance between 2010 and 2018 were included in this retrospective study. eGFR was estimated by means of Cockcroft-Gault ideal and actual weight, the Modification of Diet in Renal Disease Study (MDRD), simplified MDRD with isotope dilution mass spectroscopy traceable calibration, the Chronic Kidney Disease Epidemiology Collaboration, revised Lund-Malmo, full age spectrum, and the Berlin Initiative Study 1. Mean measured glomerular filtration rate was 42 mL/min/1.73 m(2). Pearson's correlation coefficient (r) had the highest precision for MDRD (r = 0.9), followed by revised Lund-Malmo (r = 0.88). All equations except MDRD (mean difference -4.8%) resulted in an overestimation of the renal function. The accuracy was below 75% for all equations except MDRD.

Conclusions: None of the exclusively creatinine-based methods was accurate in predicting eGFR in HF patients. Our findings suggest that more accurate methods are needed for determining eGFR in patients with HF.

Place, publisher, year, edition, pages
John Wiley & Sons, 2020. Vol. 7, no 3, p. 1150-1160
Keywords [en]
Heart failure, Renal function, Estimated glomerular filtration rate, Creatinine
National Category
Cardiac and Cardiovascular Systems
Identifiers
URN: urn:nbn:se:umu:diva-168959DOI: 10.1002/ehf2.12643ISI: 000513015500001PubMedID: 32052932Scopus ID: 2-s2.0-85079448295OAI: oai:DiVA.org:umu-168959DiVA, id: diva2:1420895
Funder
Cancerforskningsfonden i NorrlandAvailable from: 2020-04-01 Created: 2020-04-01 Last updated: 2023-03-24Bibliographically approved
In thesis
1. Mineralocorticoid receptor antagonists in heart failure: exploring the gap between guideline-directed medical therapy and real-world practice
Open this publication in new window or tab >>Mineralocorticoid receptor antagonists in heart failure: exploring the gap between guideline-directed medical therapy and real-world practice
2021 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

Heart failure is the possible end-result of a variety of different diseases, where ischemic heart disease and hypertension are the most common causes in high income countries. In Sweden, heart failure has a prevalence of 2% in the adult population and rises to over 10% among people over 70 years of age. The 5-year all-cause mortality is about 50%. To put in context, the age-adjusted 5-year mortality, first hospitalization rate and premature life-year loss were shown to be similar to those of the most common forms of cancer combined. The triad of Angiotensin-Converting Enzyme Inhibitors (ACEIs) or Angiotensin II Receptor Blockers (ARBs), Beta-blockers (BBs), and Mineralocorticoid Receptor Antagonists (MRAs) are recommended in all patients with heart failure with reduced ejection fraction (HFrEF) to decrease mortality and morbidity rates. While most eligible patients get access to treatment with ACEIs/ARBs and BBs, national and international registry and observational studies have shown that MRA treatment is largely underused in patients with HFrEF. Treatment with MRAs has shown a 15-30% relative risk reduction of all-cause mortality inpatients with HFrEF at a follow-up time of 16 to 24 months, but not even half of all eligible patients receive this treatment. The aim of this theses was to explore the pattern of MRA use in a real-world heart failure population and the reasons for MRA underuse.

With an observational retrospective study design, patients were included if they were diagnosed with heart failure at the Heart Centre or Department of Internal Medicine between January 2010 and January 2018. All patients were residents within the catchment area of the Umeå University Hospital, Sweden, and were identified by the hospital’s medical records. All data were collected from medical records. Index data were collected at the time of diagnosis, and follow-up data were collected by the journal entry closest to the end of the data collection period (2016-2018).

From the medical record content analysis, we found that contraindications including renal dysfunction, hypotension and hyperkalemia were the most common reasons for not receiving treatment with MRAs. However, almost half of those patients did not meet the guideline-directed contraindications. After excluding patients with contraindications, the underutilization of MRAs was 10%. Patients without MRAs had been hospitalized for heart failure to a much lesser extent. It is possible that this group of patients were often overlooked, which is supported by the finding that nearly one-third of these patients never had a follow-up at the cardiology clinic. Overall, we estimated that about 60% of thepatients with HFrEF would tolerate MRA treatment in the long-term, but only about 45% of the patients with HFrEF in our population were prescribed and maintained on MRAs.

Since renal dysfunction was the most common reason for not initiating MRA treatment, we wanted to evaluate how accurate eight different creatinine-based equations for estimated glomerular filtration rate (eGFR) were in heart failure patients. We showed that none of the exclusively creatinine-based equations for eGFR were accurate in predicting mGFR. All creatinine-based eGFR equations overestimated the renal function. Our findings suggests that more accurate methods are needed for determining eGFR in patients with heart failure since overestimation causes an unnecessary risk of serious adverse effects and may also lead to patients not receiving optimal guideline-directed medical therapy.

We also found that half of all patients initiated on MRAs discontinued treatment. The most common reasons for discontinuation were renal dysfunction and elevated serum-potassium but again, a majority of those did not meet guideline-directed contraindications. Independent predictors of MRA discontinuation were lower eGFR, increased serum-potassium, lower blood pressure, higher comorbidity index and higher left ventricular ejection fraction. Patients who discontinued MRAs had a higher risk of all-cause mortality after adjusting forrelevant covariates. One-third of all patients with moderately impaired renalfunction developed worsening renal function (WRF) but use of MRAs did not impact the risk. Furthermore, use of MRAs did not increase the adjusted overallrisk of mortality even when experiencing WRF.

In conclusion, there seems to be a substantial avoidable under-treatment with MRAs especially for elderly patients that are admitted to the hospital for reasons other than heart failure as well as in patients with moderately impaired renal dysfunction with mild hyperkalemia. We suggest that the risk of inadequate means of follow-up restrains optimal use of MRAs, especially in patients with moderately impaired renal function and or mild hyperkalemia that require frequent and regular laboratory monitoring to assure the safe use of MRAs. In addition, better methods are needed to accurately estimate renal function in heart failure patients. These findings contribute to the understanding of the underlying reasons behind the gap between the guideline-directed use of MRAs and real-world practice.

Place, publisher, year, edition, pages
Umeå: Umeå Universitet, 2021. p. 74
Series
Umeå University medical dissertations, ISSN 0346-6612 ; 2154
Keywords
Heart failure, Mineralocorticoid receptor antagonists, estimated glomerular filtration rate, hyperkalemia, impaired renal function, worsening renal function, guideline-directed medical therapy
National Category
Cardiac and Cardiovascular Systems
Research subject
Cardiology
Identifiers
urn:nbn:se:umu:diva-189161 (URN)978-91-7855-651-9 (ISBN)978-91-7855-650-2 (ISBN)
Public defence
2021-12-03, Bergasalen / Zoom, Norrlands Universitetssjukhus, 901 85, Umeå, 09:00 (Swedish)
Opponent
Supervisors
Note

Oregelbunden paginering

Available from: 2021-11-12 Created: 2021-11-05 Last updated: 2021-12-06Bibliographically approved

Open Access in DiVA

fulltext(1109 kB)207 downloads
File information
File name FULLTEXT01.pdfFile size 1109 kBChecksum SHA-512
f996b07f3d2bcf73ba12b72aa205b68925f442c47d0c4c167a4050a791d2d864e047abcf4daeb7ae0cf5c2e5679b59bf4abd17ae92d2ad792e7ec2e7a584a2b4
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMedScopus

Authority records

Jonsson, AnnaJonsson, AndreasValham, FredrikBergdahl, EllinorLindmark, KristerNorberg, Helena

Search in DiVA

By author/editor
Jonsson, AnnaJonsson, AndreasValham, FredrikBergdahl, EllinorLindmark, KristerNorberg, Helena
By organisation
CardiologyDepartment of Pharmacology and Clinical NeuroscienceDepartment of Integrative Medical Biology (IMB)
In the same journal
ESC Heart Failure
Cardiac and Cardiovascular Systems

Search outside of DiVA

GoogleGoogle Scholar
Total: 207 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 440 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf